Rigel Pharmaceuticals, Inc. (RIGL)
25.96
-0.14
(-0.54%)
USD |
NASDAQ |
Mar 20, 16:00
25.99
+0.03
(+0.12%)
After-Hours: 20:00
Rigel Pharmaceuticals Research and Development Expense (Quarterly) : 10.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Nektar Therapeutics | 29.68M |
| Ironwood Pharmaceuticals, Inc. | 21.40M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Amicus Therapeutics, Inc. | 23.74M |